These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3335458)

  • 21. [Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].
    Lin SJ; Pan JJ; Wu JX; Han L; Pan CZ
    Ai Zheng; 2007 Feb; 26(2):208-11. PubMed ID: 17298755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer.
    Nuyts S; Dirix P; Hermans R; Poorten VV; Delaere P; Weltens C; Van den Bogaert W
    Head Neck; 2007 Aug; 29(8):720-30. PubMed ID: 17315171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
    Garden AS; Morrison WH; Ang KK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Split-course accelerated therapy in head and neck cancer: an analysis of toxicity.
    Delaney GP; Fisher RJ; Smee RI; Hook C; Barton MB
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):763-8. PubMed ID: 7790263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
    Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
    Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
    Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric predictors of laryngeal edema.
    Sanguineti G; Adapala P; Endres EJ; Brack C; Fiorino C; Sormani MP; Parker B
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):741-9. PubMed ID: 17398024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas.
    Bourhis J; Wibault P; Lusinchi A; Bobin S; Luboinski B; Eschwege F
    Curr Opin Oncol; 1997 May; 9(3):262-6. PubMed ID: 9229149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy.
    Geara FB; Peters LJ; Ang KK; Garden AS; Tucker SL; Levy LB; Brown BW
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):455-62. PubMed ID: 8655367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerated hypofractionation (OCTA SHOT): Palliative radiation schedule in advanced head and neck carcinoma.
    Jakhar SL; Purohit R; Solanki A; Murali P; Kothari T; Sharma N; Kumar HS
    J Cancer Res Ther; 2017; 13(6):943-946. PubMed ID: 29237955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperfractionated radiotherapy in advanced squamous cell carcinoma of the head and neck.
    Nguyen TD; Panis X; Legros M; Froissart D
    Int J Radiat Oncol Biol Phys; 1983 Mar; 9(3):393-5. PubMed ID: 6841193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late onset laryngeal stenosis following radiotherapy for head and neck carcinoma: a case series.
    Jayawardena J; O'Connor TE; White R; Chai F
    ANZ J Surg; 2012 Sep; 82(9):657-8. PubMed ID: 22943085
    [No Abstract]   [Full Text] [Related]  

  • 36. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A; Azria D; Pasche P; Stupp R; Chevalier J; Betz M; Mirimanoff RO; Ozsahin M
    Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric predictors of dysphonia after intensity-modulated radiotherapy for oropharyngeal carcinoma.
    Sanguineti G; Ricchetti F; McNutt T; Wu B; Fiorino C
    Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):32-8. PubMed ID: 23992739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa.
    Gwozdz JT; Morrison WH; Garden AS; Weber RS; Peters LJ; Ang KK
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):127-35. PubMed ID: 9300747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx.
    Wendt CD; Peters LJ; Ang KK; Morrison WH; Maor MH; Goepfert H; Oswald MJ
    Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1057-62. PubMed ID: 2808039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
    Maguire PD; Meyerson MB; Neal CR; Hamann MS; Bost AL; Anagnost JW; Ungaro PC; Pollock HD; McMurray JE; Wilson EP; Kotwall CA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):698-704. PubMed ID: 14967423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.